64x Bio
Pre-clinicalDiscover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufacturing. Expert solutions for gene therapies and scalable bioengineering.
Founded
2020
Focus
Cell TherapyGene TherapySynthetic Biology
About
Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™ technology, revolutionizing cell line development and biologic manufacturing. Expert solutions for gene therapies and scalable bioengineering.
Funding History
2Total raised: $59M
Series A$55MLightspeed Venture PartnersJan 15, 2023
Seed$4MLightspeed Venture PartnersJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile